Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

It's far from over IMO. The science and trials still appear solid. No doubt poor management has resulted in significant shareholder value destruction, but the platform looks promising which is why I continue to hold. The valuation is in the gutter largely because of O'Connor's poor and self serving management for personal financial gain followed by a do nothing interim that should have been in retirement. Better days ahead I hope.